Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial. [electronic resource]
Producer: 20150921Description: 1-13 p. digitalISSN:- 1539-3704
- Administration, Oral
- Adult
- Aged
- Amides
- Antiviral Agents -- adverse effects
- Benzofurans -- adverse effects
- Carbamates
- Cyclopropanes
- Drug Administration Schedule
- Drug Therapy, Combination
- Fatigue -- chemically induced
- Female
- Genotype
- Headache -- chemically induced
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- complications
- Humans
- Imidazoles -- adverse effects
- Liver Cirrhosis -- complications
- Male
- Middle Aged
- Nausea -- chemically induced
- Quinoxalines -- adverse effects
- Sulfonamides
- Treatment Outcome
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.